Details for 2016738609

Up to date per 04.04.2026

Actions

Title / Product Name

IMMUNTHERAPEUTISCHE DOSIERSCHEMATA MIT POMALIDOMID UND EINEM ANTI-CS1-ANTIKÖRPER ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016738609

EP Publication Number

3313528

E-Number

1416350

Language

PCT Number

US16039723

Publication Date

02.05.2018 A

04.08.2021 B1

Registration Date

04.08.2021

AT Publication Date

15.08.2021

Application Date

28.06.2016

Registration Number

Priorities

29.06.2015

201562185968 P

11.10.2015

201562239965 P

03.12.2015

201562262574 P

IPC

A61P 35/02 20060101AFI20170117BHEP

Maximum Duration of Protection

28.06.2036

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

MULLIGAN, Christopher Leec/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, New Jersey 08543US

BARTLETT, Justin Blake9 Coddington CT. Basking Ridge, New Jersey 07920US

ROBBINS, Michael Darronc/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, New Jersey 08543US

Information about Fees